Lack of influence of prion protein gene expression on kainate-induced seizures in mice: Studies using congenic, coisogenic and transgenic strains

Neuroscience

Volumn 238, Issue , 2013, Pages 11-18

  Striebel, J F ^a   Race, B ^a   Pathmajeyan, M ^a   Rangel, A ^a   Chesebro, B ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

I.p.; KA; Prion; PrP; RML

Indexed keywords

KAINIC ACID; PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COISOGENIC STRAIN; CONGENIC STRAIN; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA FLANKING REGION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC COMPLEMENTATION; GENETIC VARIABILITY; MALE; MOUSE; NONHUMAN; PRION PROTEIN GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE; TRANSGENIC MOUSE;

ANIMALS; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; KAINIC ACID; MICE; MICE, TRANSGENIC; NEURONS; PRIONS; SEIZURES; SPECIES SPECIFICITY;

EID: 84875094758     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.02.004     Document Type: Article

References (24)

1. Aguzzi A., Baumann F., Bremer J. The prion's elusive reason for being. Annu Rev Neurosci 2008, 31:439-477.
2. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H.P., DeArmond S.J., Prusiner S.B., Aguet M., Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992, 356:577-582.
3. Carulla P., Bribian A., Rangel A., Gavin R., Ferrer I., Caelles C., Del Rio J.A., Llorens F. Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding. Mol Biol Cell 2011, 22:3041-3054.
4. Chesebro B., Race B., Meade-White K., Lacasse R., Race R., Klingeborn M., Striebel J., Dorward D., McGovern G., Jeffrey M. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLoS Pathog 2010, 6:e1000800.
5. Chesebro B., Trifilo M., Race R., Meade-White K., Teng C., LaCasse R., Raymond L., Favara C., Baron G., Priola S., Caughey B., Masliah E., Oldstone M. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005, 308:1435-1439.
6. Colling S.B., Collinge J., Jefferys J.G. Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents. Neurosci Lett 1996, 209:49-52.
7. Colling S.B., Khana M., Collinge J., Jefferys J.G. Mossy fibre reorganization in the hippocampus of prion protein null mice. Brain Res 1997, 755:28-35.
8. Collinge J., Whittington M.A., Sidle K.C., Smith C.J., Palmer M.S., Clarke A.R., Jefferys J.G. Prion protein is necessary for normal synaptic function. Nature 1994, 370:295-297.
9. Criado J.R., Sanchez-Alavez M., Conti B., Giacchino J.L., Wills D.N., Henriksen S.J., Race R., Manson J.C., Chesebro B., Oldstone M.B. Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis 2005, 19:255-265.
10. Curtis J., Errington M., Bliss T., Voss K., MacLeod N. Age-dependent loss of PTP and LTP in the hippocampus of PrP-null mice. Neurobiol Dis 2003, 13:55-62.
11. Fischer M., Rulicke T., Raeber A., Sailer A., Moser M., Oesch B., Brandner S., Aguzzi A., Weissmann C. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 1996, 15:1255-1264.
12. Khosravani H., Zhang Y., Tsutsui S., Hameed S., Altier C., Hamid J., Chen L., Villemaire M., Ali Z., Jirik F.R., Zamponi G.W. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 2008, 181:551-565.
13. Llorens F., Del Rio J.A. Unraveling the neuroprotective mechanisms of PrP (C) in excitotoxicity. Prion 2012, 6.
14. Mallucci G.R., Ratte S., Asante E.A., Linehan J., Gowland I., Jefferys J.G., Collinge J. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 2002, 21:202-210.
15. Manson J.C., Clarke A.R., Hooper M.L., Aitchison L., McConnell I., Hope J. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 1994, 8:121-127.
16. McCord M.C., Lorenzana A., Bloom C.S., Chancer Z.O., Schauwecker P.E. Effect of age on kainate-induced seizure severity and cell death. Neuroscience 2008, 154:1143-1153.
17. McLin J.P., Steward O. Comparison of seizure phenotype and neurodegeneration induced by systemic kainic acid in inbred, outbred, and hybrid mouse strains. Eur J Neurosci 2006, 24:2191-2202.
18. Pathmajeyan M.S., Patel S.A., Carroll J.A., Seib T., Striebel J.F., Bridges R.J., Chesebro B. Increased excitatory amino acid transport into murine prion protein knockout astrocytes cultured in vitro. Glia 2011, 59:1684-1694.
19. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972, 32:281-294.
20. Rangel A., Burgaya F., Gavin R., Soriano E., Aguzzi A., Del Rio J.A. Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis, and death: role of AMPA/kainate receptors. J Neurosci Res 2007, 85:2741-2755.
21. Ratte S., Vreugdenhil M., Boult J.K., Patel A., Asante E.A., Collinge J., Jefferys J.G. Threshold for epileptiform activity is elevated in prion knockout mice. Neuroscience 2011, 179:56-61.
22. Schauwecker P.E. Complications associated with genetic background effects in models of experimental epilepsy. Prog Brain Res 2002, 135:139-148.
23. Schauwecker P.E. The relevance of individual genetic background and its role in animal models of epilepsy. Epilepsy Res 2011, 97:1-11.
24. Walz R., Amaral O.B., Rockenbach I.C., Roesler R., Izquierdo I., Cavalheiro E.A., Martins V.R., Brentani R.R. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 1999, 40:1679-1682.